|
AHA Statements and Guidelines
Citations 331-340 of 558 total displayed.
|
Past content
(since Jan 1998):
|
- AHA Science Advisory
Antioxidant Vitamin Supplements and Cardiovascular Disease
- Penny M. Kris-Etherton, Alice H. Lichtenstein, Barbara V. Howard, Daniel Steinberg, Joseph L. Witztum for the Nutrition Committee of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism
Circulation 2004;110:637-641, doi:10.1161/01.CIR.0000137822.39831.F1
[Full text]
- NCEP Report
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
- Scott M. Grundy, James I. Cleeman, C. Noel Bairey Merz, H. Bryan Brewer, Jr, Luther T. Clark, Donald B. Hunninghake, Richard C. Pasternak, Sidney C. Smith, Jr, Neil J. Stone, for the Coordinating Committee of the National Cholesterol Education Program Endorsed by the National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, and American Heart Association
Circulation 2004;110:227-239, doi:10.1161/01.CIR.0000133317.49796.0E
[Abstract]
[Full text]
- ACC/AHA Clinical Data Standards
ACC/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation)
- Endorsed by the Mediterranean Society of Pacing and Electrophysiology, WRITING COMMITTEE MEMBERS, Robert L. McNamara, Lawrence M. Brass, Joseph P. Drozda, Jr, Alan S. Go, Jonathan L. Halperin, Charles R. Kerr, Samuel Lévy, David J. Malenka, Suneet Mittal, Frank Pelosi, Jr, Yves Rosenberg, Daniel Stryer, D. George Wyse, TASK FORCE MEMBERS, Martha J. Radford, David C. Goff, Jr, Frederick L. Grover, Paul A. Heidenreich, David J. Malenka, Eric D. Peterson, and Rita F. Redberg
Circulation 2004;109:3223-3243, doi:10.1161/01.CIR.0000131893.41821.D1
[Full text]
- ACS/ADA/AHA Scientific Statement
Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association
- Harmon Eyre, Richard Kahn, Rose Marie Robertson, the ACS/ADA/AHA Collaborative Writing Committee, ACS/ADA/AHA Collaborative Writing Committee Members, Nathaniel G. Clark, Colleen Doyle, Yuling Hong, Ted Gansler, Thomas Glynn, Robert A. Smith, Kathryn Taubert, and Michael J. Thun
Circulation 2004;109:3244-3255; published online before print as doi:10.1161/01.CIR.0000133321.00456.00
[Abstract]
[Full text]
- AHA Scientific Statements
Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases
- Barry J. Maron, Bernard R. Chaitman, Michael J. Ackerman, Antonio Bayés de Luna, Domenico Corrado, Jane E. Crosson, Barbara J. Deal, David J. Driscoll, N.A. Mark Estes, III, Claudio Gil S. Araújo, David H. Liang, Matthew J. Mitten, Robert J. Myerburg, Antonio Pelliccia, Paul D. Thompson, Jeffrey A. Towbin, Steven P. Van Camp for the Working Groups of the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention; Councils on Clinical Cardiology and Cardiovascular Disease in the Young
Circulation 2004;109:2807-2816, doi:10.1161/01.CIR.0000128363.85581.E1
[Abstract]
[Full text]
- AHA Scientific Statements
The Clinician as Investigator: Participating in Clinical Trials in the Practice Setting: Appendix 1: Fundamentals of Study Design
- Ellis W. Lader, Christopher P. Cannon, E. Magnus Ohman, L. Kristin Newby, Daniel P. Sulmasy, Robyn J. Barst, Joan M. Fair, Marcus Flather, Jane E. Freedman, Robert L. Frye, Mary M. Hand, Robert L. Jesse, Frans Van de Werf, and Fernando Costa
Circulation 2004;109:e302-304e, doi:10.1161/01.CIR.0000128807.57602.61
[Full text]
- AHA Scientific Statements
The Clinician as Investigator: Participating in Clinical Trials in the Practice Setting: Appendix 2: Statistical Concepts in Study Design and Analysis
- Ellis W. Lader, Christopher P. Cannon, E. Magnus Ohman, L. Kristin Newby, Daniel P. Sulmasy, Robyn J. Barst, Joan M. Fair, Marcus Flather, Jane E. Freedman, Robert L. Frye, Mary M. Hand, Robert L. Jesse, Frans Van de Werf, and Fernando Costa
Circulation 2004;109:e305-307e, doi:10.1161/01.CIR.0000129020.43304.A7
[Full text]
- AHA Conference Proceedings
Atherosclerotic Vascular Disease Conference: Executive Summary: Atherosclerotic Vascular Disease Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association
- David P. Faxon, Mark A. Creager, Sidney C. Smith, Jr, Richard C. Pasternak, Jeffrey W. Olin, Michael A. Bettmann, Michael H. Criqui, Richard V. Milani, Joseph Loscalzo, John A. Kaufman, Daniel W. Jones, and William H. Pearce
Circulation 2004;109:2595-2604, doi:10.1161/01.CIR.0000128517.52533.DB
[Full text]
- AHA Conference Proceedings
Atherosclerotic Vascular Disease Conference: Writing Group I: Epidemiology
- Richard C. Pasternak, Michael H. Criqui, Emelia J. Benjamin, F. Gerald R. Fowkes, Eric M. Isselbacher, Peter A. McCullough, Philip A. Wolf, and Zhi-Jie Zheng
Circulation 2004;109:2605-2612, doi:10.1161/01.CIR.0000128518.26834.93
[Full text]
- AHA Conference Proceedings
Atherosclerotic Vascular Disease Conference: Writing Group II: Risk Factors
- Sidney C. Smith, Jr, Richard V. Milani, Donna K. Arnett, John R. Crouse, III, Mary McGrae McDermott, Paul M Ridker, Robert S. Rosenson, Kathryn A. Taubert, and Peter W.F. Wilson
Circulation 2004;109:2613-2616, doi:10.1161/01.CIR.0000128519.60762.84
[Full text]
|
|
